The Subcommittee upon Management of...

The Subcommittee upon Management of Acute Otitis Media, which was conven by dint of the American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP), has released evidence-based clinical practice guidelines upon the diagnosis and management of uncomplicated acute otitis media (AOM) in children between sum of two units months and 12 years of age. The subcommittee included primary care physicians and quicks in the fields of otolaryngology, epidemiology, infectious disease, and general pediatrics. The guideline provides a specific definition of AOM and addresses pain management, initial observation versus antimicrobial treatment, appropriate choices of antimicrobials, and preventive measures. The satiated report was published in the May 2004 issue of Pediatrics.

The authors note that these guidelines are a framework for clinical decision-making and are not intended to replace clinical depth or to establish a protocol for all children with this condition. The guideline and nothing else applies to otherwise healthy children without underlying conditions that may alter the natural course of AOM (i.e., anatomic abnormalities like as cleft palate, genetic conditions similar as Down syndrome, immunodeficiencies, and the appearance of cochlear implants), and children with a clinical return of AOM within 30 days or AOM with underlying chronic otitis media with effusion.

Recommendation 1

To diagnose acute otitis media, the clinician should confirm a history of acute attack identify signs of middle-ear effusion, and evaluate for the appearance of signs and symptoms of middle-ear inflammation. (This recommendation is based forward observational studies and a preponderance of benefit across risk; see accompanying table.)

Children with AOM typically not away with a history of rapid assault of signs and symptoms, of the like kind as otalgia (pulling of the ear in an infant), irritability in an infant or toddler, otorrhea, or febrile affection A specific definition of acute otitis media is provided in the accompanying table. The report states that clinical history alone is poorly predictive of the personality of AOM, especially in younger children.

The tympanic membrane may be visualized with the use of a pneumatic otoscopy, further visualization can be supplemented by dint of tympanometry and/or acoustic reflectometry. Findings upon otoscopy that predict AOM are fullnes or bulging of the tympanic membrane combined with color and mobility.

It is difficult to distinguish between AOM and otitis media with effusion (OME) When OME is mistakenly identified as AOM, antibacterial agents may be prescribed unnecessarily. usual factors that may increase the uncertainty of a diagnosis of AOM include the inability to sufficiently clear the external auditory canal of ear-wax a narrow ear canal, and inability to maintain an adequate seal for auspicious pneumatic otoscopy or tympanometry.

Recommendation 2

The management of AOM should include an assessment of pain. If pain is at hand the clinician should recommend treatment to resolve into pain. (This is a hardy recommendation based on randomized clinical trials with limitations and a preponderance of benefit above risk.)

Many cases of AOM are associated with pain; however, physicians may behold otalgia as a peripheral make anxious not requiring direct attention. The management of pain, especially during the first 24 hours of an episode of AOM, should be addressed regardless of the use of antibacterial agents. Physicians should prefer a treatment based on a consideration of benefits and risks and, when possible, incorporate the estimations of the parent or caregiver and the patient.

Recommendation 3A

Observation without the use of antibacterial agents in a child with uncomplicated AOM is an option for preferableed children based on diagnostic certainty, age, illness severity, and assurance of follow-up (This option is based forward randomized controlled trials with limitations and a relative balance of benefit and risk.)

This "observation option" for patients with AOM involves deferring antibacterial treatment of preferableed children for 48 to 72 hours and limiting management to symptomatic relief. The decision to discover or treat is based forward the child's age, severity of illness, and diagnostic certainty. This option should be limited to otherwise healthy children six month to sum of two units years of age with non-severe illness at presentation and an uncertain diagnosis, and to children pair years of age or older without unadorned symptoms at presentation or with an uncertain diagnosis. Observation provides these patients with an opportunity to improve without the use of antibacterial agents.

Recommendation 3B

If a decision is made to treat with an antibacterial agent, the clinician should prescribe amoxicillin for principally children. (This recommendation is based in succession randomized clinical trials with limitations and a preponderance of benefit throughout risk.) When amoxicillin is used, the dosage should be 80 to 90 mg by kg per day. (This option is based forward extrapolation from microbiologic studies and [i]connoisseur[/i] opinion, with a preponderance of benefit from one side of to the other risk.)